208 related articles for article (PubMed ID: 33478016)
1. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
[TBL] [Abstract][Full Text] [Related]
2. EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases.
Zati Zehni A; Jeschke U; Hester A; Kolben T; Ditsch N; Jacob SN; Mumm JN; Heidegger HH; Mahner S; Vilsmaier T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580276
[TBL] [Abstract][Full Text] [Related]
3. Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.
Zati Zehni A; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731733
[TBL] [Abstract][Full Text] [Related]
4. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
[TBL] [Abstract][Full Text] [Related]
5. Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology.
Weissenbacher T; Hirte E; Kuhn C; Janni W; Mayr D; Karsten U; Rack B; Friese K; Jeschke U; Heublein S; Dian D; Ditsch N
BMC Cancer; 2013 Jul; 13():361. PubMed ID: 23890049
[TBL] [Abstract][Full Text] [Related]
6. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.
Ataseven B; Lederer B; Blohmer JU; Denkert C; Gerber B; Heil J; Kühn T; Kümmel S; Rezai M; Loibl S; von Minckwitz G
Ann Surg Oncol; 2015 Apr; 22(4):1118-27. PubMed ID: 25297900
[TBL] [Abstract][Full Text] [Related]
7. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
Ustaalioglu BO; Bilici A; Kefeli U; Şeker M; Oncel M; Gezen C; Gumus M; Demirelli F
Am J Clin Oncol; 2012 Dec; 35(6):580-6. PubMed ID: 21926901
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report.
Müller K; Sixou S; Kuhn C; Jalaguier S; Mayr D; Ditsch N; Weissenbacher T; Harbeck N; Mahner S; Cavaillès V; Jeschke U
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669416
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications.
Jerzak KJ; Cockburn J; Pond GR; Pritchard KI; Narod SA; Dhesy-Thind SK; Bane A
Breast Cancer Res Treat; 2015 Jan; 149(1):293-301. PubMed ID: 25542270
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
[TBL] [Abstract][Full Text] [Related]
11. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma.
Andea AA; Wallis T; Newman LA; Bouwman D; Dey J; Visscher DW
Cancer; 2002 Mar; 94(5):1383-90. PubMed ID: 11920492
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer.
Fushimi A; Yoshida A; Yagata H; Takahashi O; Hayashi N; Suzuki K; Tsunoda H; Nakamura S; Yamauchi H
Surg Today; 2019 Mar; 49(3):224-230. PubMed ID: 30317491
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node status and prognosis in multifocal and multicentric breast carcinoma.
Duraker N; Caynak ZC
Breast J; 2014; 20(1):61-8. PubMed ID: 24438065
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor, Retinoid X receptor and peroxisome proliferator-activated receptor γ are overexpressed in BRCA1 mutated breast cancer and predict prognosis.
Heublein S; Mayr D; Meindl A; Kircher A; Jeschke U; Ditsch N
J Exp Clin Cancer Res; 2017 Apr; 36(1):57. PubMed ID: 28427429
[TBL] [Abstract][Full Text] [Related]
15. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis.
Vera-Badillo FE; Napoleone M; Ocana A; Templeton AJ; Seruga B; Al-Mubarak M; AlHashem H; Tannock IF; Amir E
Breast Cancer Res Treat; 2014 Jul; 146(2):235-44. PubMed ID: 24928527
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival.
Karakas Y; Dizdar O; Aksoy S; Hayran M; Altundag K
Clin Breast Cancer; 2018 Aug; 18(4):320-327. PubMed ID: 29183716
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer.
Ditsch N; Toth B; Himsl I; Lenhard M; Ochsenkühn R; Friese K; Mayr D; Jeschke U
Histol Histopathol; 2013 Feb; 28(2):227-37. PubMed ID: 23275305
[TBL] [Abstract][Full Text] [Related]
18. Multifocal and Multicentric Breast Carcinoma: A Significantly More Aggressive Tumor than Unifocal Breast Cancer.
Lang Z; Wu Y; Li C; Li X; Wang X; Qu G
Anticancer Res; 2017 Aug; 37(8):4593-4598. PubMed ID: 28739757
[TBL] [Abstract][Full Text] [Related]
19. Increased lymph node positivity in multifocal and multicentric breast cancer.
Cabioglu N; Ozmen V; Kaya H; Tuzlali S; Igci A; Muslumanoglu M; Kecer M; Dagoglu T
J Am Coll Surg; 2009 Jan; 208(1):67-74. PubMed ID: 19228505
[TBL] [Abstract][Full Text] [Related]
20. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
